Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 10 | 2020 | 707 | 1.600 |
Why?
|
| Virus Internalization | 10 | 2024 | 97 | 1.570 |
Why?
|
| Ebolavirus | 4 | 2024 | 34 | 1.280 |
Why?
|
| Viral Envelope Proteins | 5 | 2024 | 107 | 1.230 |
Why?
|
| HIV Infections | 8 | 2020 | 919 | 1.130 |
Why?
|
| Antibodies, Neutralizing | 3 | 2020 | 192 | 1.100 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2015 | 22 | 0.900 |
Why?
|
| Antibodies, Viral | 2 | 2020 | 307 | 0.730 |
Why?
|
| Dengue | 1 | 2019 | 93 | 0.660 |
Why?
|
| Dengue Virus | 1 | 2019 | 95 | 0.650 |
Why?
|
| Protein Conformation | 3 | 2023 | 762 | 0.640 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 550 | 0.550 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 607 | 0.550 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 697 | 0.530 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2020 | 139 | 0.530 |
Why?
|
| Membrane Fusion | 4 | 2023 | 74 | 0.510 |
Why?
|
| Protein Binding | 5 | 2024 | 1545 | 0.490 |
Why?
|
| Flow Cytometry | 1 | 2016 | 670 | 0.440 |
Why?
|
| Immune Evasion | 1 | 2012 | 53 | 0.380 |
Why?
|
| HIV Antibodies | 1 | 2012 | 141 | 0.370 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 963 | 0.370 |
Why?
|
| Purinergic P2X Receptor Antagonists | 2 | 2020 | 8 | 0.330 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2024 | 24 | 0.280 |
Why?
|
| Fluorescence Resonance Energy Transfer | 3 | 2024 | 72 | 0.260 |
Why?
|
| Jurkat Cells | 2 | 2016 | 102 | 0.250 |
Why?
|
| Virus Attachment | 3 | 2024 | 23 | 0.250 |
Why?
|
| HIV Fusion Inhibitors | 2 | 2016 | 9 | 0.250 |
Why?
|
| HEK293 Cells | 4 | 2020 | 571 | 0.240 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2024 | 49 | 0.230 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 97 | 0.220 |
Why?
|
| Humans | 17 | 2024 | 59281 | 0.180 |
Why?
|
| Mutation | 3 | 2020 | 2425 | 0.170 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 195 | 0.160 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 74 | 0.160 |
Why?
|
| Palatine Tonsil | 1 | 2018 | 10 | 0.160 |
Why?
|
| Interleukin-10 | 1 | 2018 | 146 | 0.150 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 263 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2024 | 427 | 0.140 |
Why?
|
| Viremia | 1 | 2017 | 44 | 0.140 |
Why?
|
| Receptors, IgG | 1 | 2017 | 36 | 0.140 |
Why?
|
| Cell Line | 4 | 2016 | 2014 | 0.140 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2016 | 36 | 0.130 |
Why?
|
| Virology | 1 | 2016 | 13 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2016 | 197 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 96 | 0.130 |
Why?
|
| Cell Communication | 1 | 2016 | 129 | 0.120 |
Why?
|
| HIV Protease | 1 | 2016 | 121 | 0.120 |
Why?
|
| Amino Acid Motifs | 1 | 2015 | 152 | 0.120 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 451 | 0.120 |
Why?
|
| Point Mutation | 1 | 2015 | 162 | 0.120 |
Why?
|
| Purinergic Antagonists | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptors, Purinergic P2X | 1 | 2014 | 2 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 177 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 253 | 0.120 |
Why?
|
| Virion | 1 | 2014 | 117 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 663 | 0.110 |
Why?
|
| Cervix Uteri | 1 | 2013 | 57 | 0.110 |
Why?
|
| Allosteric Regulation | 2 | 2024 | 69 | 0.100 |
Why?
|
| Protein Domains | 2 | 2024 | 138 | 0.100 |
Why?
|
| CD4 Antigens | 1 | 2012 | 155 | 0.090 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 10 | 0.090 |
Why?
|
| Epitopes | 1 | 2012 | 298 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2013 | 375 | 0.090 |
Why?
|
| Virus Replication | 3 | 2016 | 303 | 0.080 |
Why?
|
| Calcium | 2 | 2023 | 552 | 0.080 |
Why?
|
| Cell Membrane | 2 | 2024 | 489 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 869 | 0.070 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2017 | 94 | 0.070 |
Why?
|
| Immunity, Innate | 1 | 2011 | 764 | 0.060 |
Why?
|
| Single Molecule Imaging | 1 | 2024 | 21 | 0.060 |
Why?
|
| Endosomes | 1 | 2023 | 170 | 0.050 |
Why?
|
| Binding Sites | 1 | 2024 | 874 | 0.050 |
Why?
|
| Animals | 2 | 2016 | 19595 | 0.040 |
Why?
|
| Zidovudine | 1 | 2018 | 12 | 0.040 |
Why?
|
| Benzenesulfonates | 1 | 2018 | 15 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2018 | 20 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 31 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2020 | 144 | 0.040 |
Why?
|
| Virulence | 1 | 2018 | 189 | 0.040 |
Why?
|
| Pyridines | 1 | 2018 | 98 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 322 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2018 | 306 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2017 | 19 | 0.030 |
Why?
|
| Reproductive Tract Infections | 1 | 2016 | 1 | 0.030 |
Why?
|
| Virus Release | 1 | 2016 | 14 | 0.030 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 106 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 926 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2014 | 32 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2014 | 45 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2014 | 57 | 0.030 |
Why?
|
| Models, Biological | 1 | 2018 | 1138 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2013 | 47 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 374 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2013 | 265 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1536 | 0.020 |
Why?
|
| Birds | 1 | 2011 | 8 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 238 | 0.020 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2011 | 37 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2011 | 83 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2011 | 105 | 0.020 |
Why?
|
| Female | 3 | 2017 | 30797 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 236 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2016 | 1456 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2017 | 2885 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2102 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 16231 | 0.010 |
Why?
|
| Male | 1 | 2017 | 27479 | 0.010 |
Why?
|